Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (39)

« Back to Publications

Editorial: Lipids in immunometabolism.

Nicoli F. et al, (2026), Front Immunol, 17

Hypercholesterolaemia promotes epigenetic memory in hematopoietic stem cells that persists after lipid lowering and causes systemic immunometabolic dysfunction mediated by macrophage metabolic reprogramming

Purvis GSD. et al, (2025)

Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.

Purvis GSD. et al, (2025), Diabetologia, 68

Correction: RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance.

Chen J. et al, (2025), Front Immunol, 16

Ly6Chi Monocytes Are Metabolically Reprogrammed in the Blood during Inflammatory Stimulation and Require Intact OxPhos for Chemotaxis and Monocyte to Macrophage Differentiation.

Purvis GSD. et al, (2024), Cells, 13

Drug repurposing screen identifies novel anti-inflammatory activity of sunitinib in macrophages.

Chaffey LE. et al, (2024), Eur J Pharmacol, 969

OxPhos in adipose tissue macrophages regulated by BTK enhances their M2-like phenotype and confers a systemic immunometabolic benefit in obesity.

Purvis GSD. et al, (2024), Diabetes

OxPhos in adipose tissue macrophages regulated by BTK enhances their M2-like phenotype and confers a systemic immunometabolic benefit in obesity

Purvis G. et al, (2023)

Multityrosine kinase inhibitor sunitinib has anti-inflammatory activity in macrophages mediated via inhibition of NF-κB

Chaffey L. et al, (2023), BRITISH JOURNAL OF PHARMACOLOGY, 180, 536 - 537

Bruton's TK regulates myeloid cell recruitment during acute inflammation.

Purvis GSD. et al, (2022), Br J Pharmacol, 179, 2754 - 2770

A Human CD68 Promoter-Driven Inducible Cre-Recombinase Mouse Line Allows Specific Targeting of Tissue Resident Macrophages.

Rumianek AN. et al, (2022), Front Immunol, 13

Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood-brain barrier: Therapeutic avenues.

Sheikh MH. et al, (2022), FASEB J, 36

Selected Abstracts from Pharmacology 2021.

(2021), Br J Pharmacol, 178, 4923 - 5006

A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice.

Mohammad S. et al, (2021), Front Immunol, 12

Bruton’s tyrosine kinase (BTK) regulates myeloid cell recruitment during acute inflammation

Purvis G. et al, (2021)

Load More